Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-27 2:22 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Logos Global Management LP | 5,000,000 7.800% | 5,000,000 (New Position) | View |
| 2024-11-12 4:30 pm Sale | 13G | GLYCOMIMETICS INC GLYC | Invus Global Management LLC | 1,965,114 3.000% | -3,323,394 (-62.84%) | View |
| 2024-11-06 5:41 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | RA CAPITAL MANAGEMENT L.P. | 6,383,000 9.900% | 6,383,000 (New Position) | View |
| 2024-11-04 4:26 pm Purchase | 13D | GLYCOMIMETICS INC GLYC | Adage Capital Management L.P. | 5,091,231 7.900% | 5,091,231 (New Position) | View |
| 2024-08-15 5:01 pm Sale | 13G | GLYCOMIMETICS INC GLYC | Invus Global Management LLC | 5,288,508 8.200% | -3,300,556 (-38.43%) | View |
| 2024-07-29 7:24 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Invus Global Management LLC | 8,589,064 13.300% | 8,589,064 (New Position) | View |
| 2024-05-08 5:06 pm Sale | 13D | GLYCOMIMETICS INC GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 0 0.000% | -4,007,977 (Position Closed) | View |
| 2024-02-29 7:28 pm Sale | 13D | GLYCOMIMETICS INC GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 4,007,977 6.200% | -713,899 (-15.12%) | View |
| 2024-02-12 4:48 pm Sale | 13D | GLYCOMIMETICS INC GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 4,721,876 7.300% | -245,654 (-4.95%) | View |
| 2024-02-09 5:03 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Artal International S.C.A. | 8,589,064 13.300% | 2,015,266 (+30.66%) | View |
| 2024-01-29 4:31 pm Unchanged | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 9,544,262 14.800% | 0 (Unchanged) | View |
| 2023-02-13 5:18 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Artal International S.C.A. | 6,573,798 12.500% | 6,573,798 (New Position) | View |
| 2023-02-10 5:23 pm Sale | 13D | GLYCOMIMETICS INC GLYC | NEW ENTERPRISE ASSOCIATES 10 L P | 4,967,530 9.500% | -4,143,797 (-45.48%) | View |
| 2022-02-10 08:11 am Sale | 13G | GLYCOMIMETICS INC GLYC | VANGUARD GROUP INC | 2,238,553 4.330% | -330,686 (-12.87%) | View |
| 2021-07-12 08:29 am Sale | 13G | GLYCOMIMETICS INC GLYC | BlackRock Inc. BLK | 886,148 1.700% | -1,730,329 (-66.13%) | View |
| 2021-02-16 08:24 am Sale | 13G | GLYCOMIMETICS INC GLYC | Camber Capital Management LP | 2,200,000 4.600% | -1,300,000 (-37.14%) | View |
| 2021-02-12 3:42 pm Sale | 13G | GLYCOMIMETICS INC GLYC | EcoR1 Capital LLC | 0 0.000% | -2,909,800 (Position Closed) | View |
| 2021-02-11 5:14 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 9,544,262 19.960% | 2,182,461 (+29.65%) | View |
| 2021-02-10 10:57 am Purchase | 13G | GLYCOMIMETICS INC GLYC | VANGUARD GROUP INC | 2,569,239 5.370% | 2,569,239 (New Position) | View |
| 2021-01-29 09:57 am Sale | 13G | GLYCOMIMETICS INC GLYC | BlackRock Inc. BLK | 2,616,477 5.500% | -212,034 (-7.50%) | View |